Basic Information
RNALocate ID: | RLID:01002049 |
RNA Symbol: | hsa-miR-330-3p |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-330-3p |
RNA ID: | miRBase:MIMAT0000751 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22984580 |
Tissue/Cell Line: | Cell line (HEK-293|HeLa) |
Method: | Next-generation RNA sequencing |
Description: | The differential association of miRNA to mitochondria of both HEK293 and HeLa has been summarized in Table S3. Data are collected from Table S3: Pattern of miRNAs associated with mitochondria of HEK293 and HeLa. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002048 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002050 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11002572 | Exosome | Serum | 18589210 |
RLID:11002573 | Exosome | Primary dendritic cells | 21505438 |
RLID:11002574 | Exosome | Brain tissue | 23382797 |
RLID:11002575 | Exosome | Plasma | 23663360 |
RLID:11002576 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000127 | Exosome | Blood | |
RLID-D:11000428 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-330-3p | Restless legs syndrome | MNDR-E-MI-40529 |
MNDR | hsa-miR-330-3p | Splenic marginal zone lymphoma | MNDR-E-MI-40530 |
MNDR | hsa-miR-330-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-40531 |
MNDR | hsa-miR-330-3p | Oral squamous cell carcinoma | MNDR-E-MI-40532 |
MNDR | hsa-miR-330-3p | Follicular lymphoma | MNDR-E-MI-40533 |
MNDR | hsa-miR-330-3p | Medulloblastoma | MNDR-E-MI-40534 |
MNDR | hsa-miR-330-3p | Lymphoma non-hodgkin | MNDR-E-MI-40535 |
MNDR | hsa-miR-330-3p | Her2-receptor positive breast cancer | MNDR-E-MI-40536 |
MNDR | hsa-miR-330-3p | Prostate cancer | MNDR-E-MI-40537 |
MNDR | hsa-miR-330-3p | Gastric cancer | MNDR-E-MI-40538 |
MNDR | hsa-miR-330-3p | Alzheimer disease | MNDR-E-MI-40539 |
MNDR | hsa-miR-330-3p | Intracranial aneurysm | MNDR-E-MI-40540 |
MNDR | hsa-miR-330-3p | Dysautonomia familial | MNDR-E-MI-40541 |
MNDR | hsa-miR-330-3p | Polycystic ovary syndrome | MNDR-E-MI-40542 |
MNDR | hsa-miR-330-3p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-40543 |
MNDR | hsa-miR-330-3p | Leukemia | MNDR-E-MI-40544 |
MNDR | hsa-miR-330-3p | Huntington disease | MNDR-E-MI-40545 |
MNDR | hsa-miR-330-3p | Chorea | MNDR-E-MI-40546 |
MNDR | hsa-miR-330-3p | Cardiovascular disease | MNDR-E-MI-40547 |
MNDR | hsa-miR-330-3p | Lung cancer | MNDR-E-MI-40548 |
MNDR | hsa-miR-330-3p | Parkinson disease | MNDR-E-MI-40549 |
MNDR | hsa-miR-330-3p | Breast cancer | MNDR-E-MI-40550 |
MNDR | hsa-miR-330-3p | Squamous cell carcinoma | MNDR-E-MI-40551 |
MNDR | hsa-miR-330-3p | Thyroid cancer | MNDR-E-MI-40552 |
MNDR | hsa-miR-330-3p | Pancreatic cancer | MNDR-E-MI-40553 |
MNDR | hsa-miR-330-3p | Melanoma | MNDR-E-MI-40554 |
MNDR | hsa-miR-330-3p | Nephroblastoma | MNDR-E-MI-40555 |
MNDR | hsa-miR-330-3p | Colon cancer | MNDR-E-MI-40556 |
MNDR | hsa-miR-330-3p | Colon adenocarcinoma | MNDR-E-MI-40557 |
MNDR | hsa-miR-330-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-40558 |
MNDR | hsa-miR-330-3p | Prostate adenocarcinoma | MNDR-E-MI-40559 |
MNDR | hsa-miR-330-3p | Carcinoma ductal breast | MNDR-E-MI-40560 |
MNDR | hsa-miR-330-3p | Glioblastoma | MNDR-E-MI-40561 |
MNDR | hsa-miR-330-3p | Glioma | MNDR-E-MI-40562 |
MNDR | hsa-miR-330-3p | Oligodendroglioma | MNDR-E-MI-40563 |
MNDR | hsa-miR-330-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-40564 |
MNDR | hsa-miR-330-3p | Temporal lobe epilepsy | MNDR-E-MI-40565 |
MNDR | hsa-miR-330-3p | Osteosarcoma | MNDR-E-MI-40566 |
MNDR | hsa-miR-330-3p | Liver cancer | MNDR-E-MI-40567 |
MNDR | hsa-miR-330-3p | Uterine cancer | MNDR-E-MI-40568 |
MNDR | hsa-miR-330-3p | Lung squamous cell carcinoma | MNDR-E-MI-40569 |
MNDR | hsa-miR-330-3p | Carcinoma lung non-small-cell | MNDR-E-MI-40570 |
MNDR | hsa-miR-330-3p | Lung adenocarcinoma | MNDR-E-MI-40571 |
MNDR | hsa-miR-330-3p | Bladder urothelial carcinoma | MNDR-E-MI-40572 |
MNDR | hsa-miR-330-3p | Pancreatic adenocarcinoma | MNDR-E-MI-40573 |
MNDR | hsa-miR-330-3p | Carcinoma renal cell | MNDR-E-MI-40574 |
MNDR | hsa-miR-330-3p | Papillary renal cell carcinoma | MNDR-E-MI-40575 |
MNDR | hsa-miR-330-3p | Clear cell renal cell carcinoma | MNDR-E-MI-40576 |
MNDR | hsa-miR-330-3p | Esophageal cancer | MNDR-E-MI-40577 |
MNDR | hsa-miR-330-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-40578 |
MNDR | hsa-miR-330-3p | T acute lymphoblastic leukemia | MNDR-E-MI-40579 |
MNDR | hsa-miR-330-3p | Acute t cell leukemia | MNDR-E-MI-40580 |
MNDR | hsa-miR-330-3p | Encephalomyelitis | MNDR-E-MI-40581 |
MNDR | hsa-miR-330-3p | Breast invasive carcinoma | MNDR-E-MI-40582 |
MNDR | hsa-miR-330-3p | Hepatocellular carcinoma | MNDR-E-MI-40583 |
MNDR | hsa-miR-330-3p | B-cell lymphoma | MNDR-E-MI-40584 |
MNDR | hsa-miR-330-3p | Rheumatoid arthritis | MNDR-E-MI-40585 |
MNDR | hsa-miR-330-3p | T-cell leukemia | MNDR-E-MI-40586 |
MNDR | hsa-miR-330-3p | Neuroblastoma | MNDR-E-MI-40587 |
MNDR | hsa-miR-330-3p | Hodgkin lymphoma | MNDR-E-MI-40588 |
MNDR | hsa-miR-330-3p | Burkitt lymphoma | MNDR-E-MI-40589 |
MNDR | hsa-miR-330-3p | Tonsil cancer | MNDR-E-MI-40590 |
MNDR | hsa-miR-330-3p | Neuromyelitis optica | MNDR-E-MI-40591 |
MNDR | hsa-miR-330-3p | Skin cutaneous melanoma | MNDR-E-MI-40592 |
MNDR | hsa-miR-330-3p | Skin melanoma | MNDR-E-MI-40593 |
MNDR | hsa-miR-330-3p | Colorectal cancer | MNDR-E-MI-40594 |
MNDR | hsa-miR-330-3p | Multiple myeloma | MNDR-E-MI-40595 |
MNDR | hsa-miR-330-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-40596 |
MNDR | hsa-miR-330-3p | Stroke lacunar | MNDR-E-MI-40597 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CCBE1 | Homo sapiens | RR00287411 |
TOP